Nyxoah Financials
NYXH Stock | USD 10.51 0.46 4.58% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.14 | 0.15 |
|
| |||||
Current Ratio | 6.33 | 4.26 |
|
|
The essential information of the day-to-day investment outlook for Nyxoah includes many different criteria found on its balance sheet. An individual investor should monitor Nyxoah's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Nyxoah.
Net Income |
|
Nyxoah | Select Account or Indicator |
Nyxoah Stock Summary
Nyxoah competes with Milestone Scientific, Pro Dex, InfuSystems Holdings, Repro Med, and JIN MEDICAL. Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Nyxoah S is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | BE0974358906 |
CUSIP | B6S7WD106 |
Location | Belgium |
Business Address | Rue Edouard Belin |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.nyxoah.com |
Phone | 32 10 22 23 55 |
Currency | USD - US Dollar |
Nyxoah Key Financial Ratios
Return On Equity | -0.56 | ||||
Operating Margin | (14.50) % | ||||
Price To Sales | 87.41 X | ||||
Revenue | 4.35 M | ||||
Gross Profit | 2.97 M |
Nyxoah Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 114.1M | 170.8M | 146.1M | 124.2M | 142.8M | 94.2M | |
Other Current Liab | 4.5M | 5.2M | 8.3M | 7.1M | 8.2M | 4.5M | |
Net Tangible Assets | 10.5M | 667K | 96.6M | 148.1M | 170.3M | 178.8M | |
Net Debt | (80.8M) | (123.8M) | (6.0M) | (8.9M) | (8.0M) | (8.4M) | |
Retained Earnings | (60.3M) | (87.2M) | (118.2M) | (160.8M) | (144.7M) | (137.5M) | |
Accounts Payable | 815K | 2.4M | 1.9M | 4.1M | 4.7M | 5.0M | |
Cash | 92.3M | 135.5M | 17.9M | 21.6M | 24.9M | 47.2M | |
Other Assets | 97K | 5.5M | 15.4M | 25.0M | 28.7M | 30.2M | |
Long Term Debt | 7.6M | 7.8M | 8.2M | 8.4M | 9.6M | 7.8M | |
Net Receivables | 1.6M | 2.5M | 1.8M | 2.8M | 3.2M | 1.9M | |
Other Current Assets | 109K | 1.7M | 2.7M | 4.5M | 5.2M | 5.5M | |
Total Liab | 16.9M | 22.2M | 25.7M | 26.1M | 30.1M | 18.3M | |
Net Invested Capital | 105.4M | 157.0M | 128.9M | 106.8M | 122.8M | 84.1M | |
Short Long Term Debt | 616K | 554K | 388K | 364K | 418.6K | 468.9K | |
Total Current Assets | 94.1M | 140.1M | 100.3M | 68.4M | 78.6M | 69.0M | |
Net Working Capital | 87.7M | 128.5M | 85.3M | 53.9M | 62.0M | 60.4M | |
Short Term Debt | 1.1M | 1.1M | 1.1M | 1.2M | 1.4M | 935K | |
Common Stock | 3.8M | 4.4M | 4.4M | 4.9M | 5.7M | 3.9M | |
Capital Stock | 3.8M | 4.4M | 4.4M | 4.9M | 5.7M | 4.1M | |
Intangible Assets | 15.9M | 25.3M | 40.0M | 465K | 534.8K | 508.0K |
Nyxoah Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | 93K | 3.0M | 1.2M | (329K) | (378.4K) | (359.4K) | |
Net Interest Income | (967K) | (1.6M) | 2.4M | 1.1M | 1.2M | 1.3M | |
Interest Expense | 198K | 2.1M | 4.3M | 1.2M | 1.4M | 1.2M | |
Total Revenue | 69K | 852K | 3.1M | 4.3M | 5.0M | 5.3M | |
Gross Profit | 39K | 549K | 1.9M | 2.7M | 3.1M | 3.3M | |
Operating Income | (11.2M) | (26.2M) | (32.5M) | (45.1M) | (40.6M) | (38.6M) | |
Ebit | (11.2M) | (26.2M) | (29.8M) | (44.4M) | (40.0M) | (38.0M) | |
Research Development | 2.9M | 6.0M | 15.9M | 27.7M | 31.8M | 33.4M | |
Ebitda | (10.6M) | (24.6M) | (27.9M) | (42.1M) | (37.9M) | (36.0M) | |
Cost Of Revenue | 30K | 303K | 1.2M | 1.7M | 1.5M | 937.7K | |
Income Before Tax | (12.2M) | (24.6M) | (30.1M) | (44.7M) | (40.2M) | (38.2M) | |
Net Income | (12.2M) | (27.6M) | (31.2M) | (43.2M) | (38.9M) | (36.9M) | |
Income Tax Expense | 93K | 3.0M | 1.2M | (1.4M) | (1.7M) | (1.6M) |
Nyxoah Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Investments | (10.7M) | (11.8M) | (89.9M) | (47.1M) | (42.3M) | (40.2M) | |
Change In Cash | 86.4M | 43.2M | (117.6M) | 3.7M | 3.3M | 3.5M | |
Free Cash Flow | (17.7M) | (37.2M) | (45.1M) | (55.7M) | (50.2M) | (47.7M) | |
Depreciation | 620K | 1.7M | 1.9M | 2.4M | 2.7M | 2.8M | |
Other Non Cash Items | 794K | (2.2M) | (3.4M) | (1.6M) | (1.4M) | (1.4M) | |
Capital Expenditures | 10.7M | 11.8M | 16.3M | 11.0M | 12.6M | 8.8M | |
Net Income | (12.2M) | (24.6M) | (30.1M) | (44.7M) | (40.2M) | (38.2M) | |
End Period Cash Flow | 92.3M | 135.5M | 17.9M | 21.6M | 24.9M | 47.2M | |
Change To Netincome | 644K | 1.1M | 3.2M | 1.8M | 2.0M | 2.0M |
Nyxoah Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nyxoah's current stock value. Our valuation model uses many indicators to compare Nyxoah value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nyxoah competition to find correlations between indicators driving Nyxoah's intrinsic value. More Info.Nyxoah is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Nyxoah's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nyxoah's earnings, one of the primary drivers of an investment's value.Nyxoah Systematic Risk
Nyxoah's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nyxoah volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Nyxoah correlated with the market. If Beta is less than 0 Nyxoah generally moves in the opposite direction as compared to the market. If Nyxoah Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nyxoah is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nyxoah is generally in the same direction as the market. If Beta > 1 Nyxoah moves generally in the same direction as, but more than the movement of the benchmark.
Nyxoah Thematic Clasifications
Nyxoah is part of several thematic ideas from Medical Equipment to Office Supplies. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Nyxoah Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nyxoah's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nyxoah growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Nyxoah March 17, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nyxoah help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nyxoah. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nyxoah based on widely used predictive technical indicators. In general, we focus on analyzing Nyxoah Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nyxoah's daily price indicators and compare them against related drivers.
Downside Deviation | 1.89 | |||
Information Ratio | 0.2058 | |||
Maximum Drawdown | 18.32 | |||
Value At Risk | (3.79) | |||
Potential Upside | 7.83 |
Complementary Tools for Nyxoah Stock analysis
When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |